Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Pediatr Dermatol ; 34(3): e116-e119, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28523894

RESUMO

Cutaneous mucormycosis is a rare but often fatal invasive fungal infection that occurs most commonly in patients with diabetes, malignancy, and other immunocompromising conditions. We report an extremely preterm (<28 weeks) baby boy who developed polymicrobial sepsis and primary cutaneous mucormycosis within his first 10 days of life. He was successfully treated with medical management alone since he was not a candidate for surgery. Successful treatment of cutaneous mucormycosis without surgical debridement has been reported on only two other occasions. This case highlights the importance of rapid and thorough evaluation of skin lesions when evaluating preterm infants and other immunocompromised patients, even when other sources of infection have been identified.


Assuntos
Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Dermatomicoses/diagnóstico , Dermatomicoses/tratamento farmacológico , Lactente Extremamente Prematuro , Mucormicose/microbiologia , Rhizopus/ultraestrutura , Dermatomicoses/microbiologia , Seguimentos , Humanos , Recém-Nascido , Masculino , Monitorização Fisiológica , Mucormicose/tratamento farmacológico , Medição de Risco , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA